Pharmacokinetics of ASP7991 Clinical Trial
Official title:
ASP7991 Clinical Pharmacological Study -Examination of Pharmacokinetics and Pharmacodynamics in Chronic Kidney Disease Patients Undergoing Hemodialysis
This study is to assess the safety, tolerability, plasma concentration and pharmacodynamics of ASP7991 after oral administration to patients with chronic kidney disease undergoing hemodialysis.
To examine the pharmacokinetics, pharmacodynamics and safety in patients with chronic kidney
disease undergoing hemodialysis.
- To assess the pharmacokinetics (PK), pharmacodynamics (PD), safety and the effect of
hemodialysis on PK of single oral administration of ASP7991 in Part 1.
- To assess the safety, PK and PD of repeated oral administration of ASP7991 in part 2.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01872013 -
Multiple Oral Administration of ASP7991 to Non-elderly Male Subjects
|
Phase 1 | |
| Completed |
NCT01675518 -
A Study to Assess the Safety, Pharmacological Effect and Plasma Concentration of ASP7991 After Single Oral Administration to Healthy Volunteers
|
Phase 1 |